Applied Finance Capital Management’s Boston Scientific BSX Stock Holding History

Applied Finance Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$695K	Buy	+16,285	New	+$884K	0.05%	130

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Applied Finance Capital Management's BSX Position: Q2 2026 in Review

Applied Finance Capital Management opened a new position in Boston Scientific (BSX) in Q2 2026: 16,285 shares worth $695K. The stake represents 0.05% of the portfolio and ranks #130 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Applied Finance Capital Management held 16,285 shares of Boston Scientific worth $695K as of Q2 2026.
Boston Scientific was a new Applied Finance Capital Management position in Q2 2026.
Boston Scientific made up 0.05% of Applied Finance Capital Management's portfolio in Q2 2026, its #130 holding.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.